Buy or sell H1 stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

H1 Stock

H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems.

About H1 Stock

H1 provides the largest global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organization. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.

Funding History

March 2020$12.9M
December 2020$58.0M

Management

CEO and Co-Founder

Ariel Katz

Co-Founder

Ian Sax

VP of Commercial Strategy and Operations

Zachary Feuerstein

Director Of Innovation

Callum Booker

Chief Of Staff

Andrew Stickney

VP Innovation

Devin Basinger

Senior Director

Raymond Jacobs

CCO

Marc Eigner

Board Member

Greg Yap

Board Observer

Jean-Paul Sanday

Director, Customer Support

Jason Viglione

Board Observer

Michael Miao

Board Observer

Deena Shakir

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from H1 or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 180K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo